Cara Therapeutics | CARA - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Assertio Holdings USD 758K 1000 2024-06
Cara Therapeutics -89.64M 128.67M 2025-12
Cassava Sciences USD 108.37M 396.06M 2026-03
Chugai Pharma JPY 95M 260M 2025-12
Cipla INR 131.3M 9M 2026-03
Compugen USD 954K 116K 2025-09
CSL USD 215M 111M 2025-12
Grifols EUR 156.07M 31.46M 2025-09
Halozyme Therapeutics USD 5.51M 597K 2026-03
J&J USD 43M 25M 2026-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Pacira USD 3.7M 193K 2026-03
Pfizer USD 671M 40M 2026-03
RedHill Biopharma USD 89.8K 31.69M 2024-06
Supernus Pharmaceuticals USD 910K 278K 2023-06
Vanda Pharmaceuticals -1.37B 1.97B 2025-12